Dr. Gray received his Bachelor’s Degree, MD, and PhD in Biochemistry from Case Western Reserve University. During his undergraduate years, Dr. Gray was honored with the Undergraduate Psychiatry Research Award, inducted into the Phi Beta Kappa Honor Society, and graduated summa cum laude. He has received several other prestigious awards, including the NARSAD Young Investigator Award, the Langley Porter Psychiatry Institute Resident Research Award, and the 2007 NIMH Outstanding Resident Award in Psychiatric Research for which he was one of ten individuals chosen nationally to receive this award. More recently, he has received a travel award to the 2013 Society of Biological Psychiatry meeting and was awarded a K08 Career Development Award from the NIMH.
In the RRTP and currently, Dr. Gray is working with Roger Nicoll, MD as a research fellow on a project that seeks to determine how proteins encoded by schizophrenia susceptibility genes regulate glutamate receptor expression, function, and regulation. The primary methodological approach is targeted genetic manipulation of single neurons in the mouse hippocampus and dual whole-cell patch clamp electrophysiology of CA1 hippocampal synapses.
Dr. Gray has thirteen original publications (seven as first-author), nine review articles, and four book chapters. Two of his recent reviews include a featured review in Molecular Psychiatry on the future of drug discovery and schizophrenia and a review on molecular targets for treating the cognitive dysfunction in schizophrenia, which was published in Schizophrenia Bulletin.
Dr. Gray’s publications: https://sites.google.com/site/johnalangraymdphd/